Literature DB >> 20414172

Cerebrotendinous xanthomatosis presenting with severe externalized disorder: improvement after one year of treatment with chenodeoxycholic Acid.

Olivier Bonnot1, Matthew J Fraidakis, Raffaella Lucanto, Dominique Chauvin, Nathalie Kelley, Monique Plaza, Odile Dubourg, Olivier Lyon-Caen, Frédéric Sedel, David Cohen.   

Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare inborn disorder of sterol storage with autosomal recessive inheritance and a variable clinical presentation. We describe two siblings with an early psychiatric presentation of CTX-associated attention-deficit/hyperactivity disorder and oppositional defiant disorder, also associated with a mild intellectual disability and major behavioral impairments. In both cases, treatment with chenodeoxycholic acid improved externalized symptoms and a partial recovery of cognitive impairments was observed. This suggests that CTX is potentially reversible, demonstrating the need for early diagnosis and treatment of this disorder before irreversible neurological lesions can occur.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414172     DOI: 10.1017/s1092852900000067

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  8 in total

1.  A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.

Authors:  Mohamed S Abdel-Hamid; Mahmoud Y Issa; Ghada A Otaify; Maha S Zaki
Journal:  Metab Brain Dis       Date:  2017-02-22       Impact factor: 3.584

Review 2.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

Review 3.  Secondary psychosis induced by metabolic disorders.

Authors:  Olivier Bonnot; Paula M Herrera; Sylvie Tordjman; Mark Walterfang
Journal:  Front Neurosci       Date:  2015-05-19       Impact factor: 4.677

Review 4.  Psychiatric manifestations in cerebrotendinous xanthomatosis.

Authors:  M J Fraidakis
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

Review 5.  Psychiatric manifestations of treatable hereditary metabolic disorders in adults.

Authors:  Caroline Demily; Frédéric Sedel
Journal:  Ann Gen Psychiatry       Date:  2014-09-24       Impact factor: 3.455

6.  Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood.

Authors:  Bertrand Degos; Yann Nadjar; Maria del Mar Amador; Foudil Lamari; Frédéric Sedel; Emmanuel Roze; Philippe Couvert; Fanny Mochel
Journal:  Orphanet J Rare Dis       Date:  2016-04-16       Impact factor: 4.123

7.  Targeted metabolomics reveals aberrant profiles of serum bile acids in patients with schizophrenia.

Authors:  Ying Qing; Pengkun Wang; Gaoping Cui; Juan Zhang; Kemei Liang; Zhong Xia; Peng Wang; Lin He; Wei Jia
Journal:  Schizophrenia (Heidelb)       Date:  2022-08-18

Review 8.  Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.

Authors:  Olivier Bonnot; Hans Hermann Klünemann; Frederic Sedel; Sylvie Tordjman; David Cohen; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2014-04-28       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.